The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis
Abstract
Objective To conduct a meta-analysis of studies assessing abnormal glucose metabolism (AGM) prevalence among patients with primary aldosteronism (PA), calculating a combined pooled prevalence and summarizing metabolic parameters associated the pooled prevalence for comparative group. Method Four electronic databases (PubMed, EMBASE, Cochrane CENTRAL, and ISI-Web of Science) were systematically retrieved with no language and time restriction. Studies about elevated level of glucose metabolism in primary aldosteronism were included. Result Data were available in 16 studies. The pooled analysis revealed that the prevalence of elevated glucose in PA was 22.41 % (95 % CI 16.77-28.05 %), the retrospectively calculated prevalence was 31.20 % (95 % CI 15.81-46.60 %) for impaired fasting glucose, 26.19 % (95 % CI 15.17-37.21 %) for impaired glucose tolerance, 15.22 % (95 % CI 9.93-20.51 %) for diabetes mellitus. Prevalence of AGM in PA was higher than that in essential hypertension (OR = 1.55, 95 % CI 1.01-2.36, p = 0.04). From comparative groups, patients with primary aldosteronism had a lower level of insulin sensitivity indicators in comparison with normal group (p Conclusion There is a significant prevalence of elevated level of glucose metabolism in patients with PA. Awareness and treatment of this pre-diabetic or diabetic state are necessary.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chen et al. conducted a meta-analysis and systematic review and found that PA patients are at an increased risk for impaired glucose homeostasis (e.g. IFG, IGT, T2D) as compared to essential hypertensives [20].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [20]
In the citing paper
“However, when compared with normotensive cohorts, reduced insulin sensitivity has been reported in PA patients [19,9,20,13,8,21,22].”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [20]
In the citing paper
“However, the effects of hyperaldosteronism on insulin sensitivity and β-cell function are unclear.”
From Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism (2021) · cites this paper as [20]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“Egger’s linear regression [16] was generated, and Begg’s funnel plots [17] were used to examine potential publication bias related to the prevalence of abnormal glucose metabolism.”
MethodMeta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · cited 1×
“Egger’s linear regression [16] was generated, and Begg’s funnel plots [17] were used to examine potential publication bias related to the prevalence of abnormal glucose metabolism.”
MethodInterval Estimation for a Binomial Proportion
Brown, L. D., Cai, T. T., & DasGupta, A. (2001) · Statistical Science · doi:10.1214/ss/1009213286 · Cited by 3,538 · cited 1×
“In the result page, the 95 % CI from normal approximation method was used once np [ 5 or n (1-p)[5 [14], where n and p, respectively, represented the summarized number and prevalence in PA or EH group.”
MethodPrevalence of mental health conditions in cancer patients in acute care—a meta-analysis
Singer, S., Das-Munshi, J., & Brähler, E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp515 · Cited by 392
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372 · cited 3×
“Whereas, according to five available studies in EH group [2, 21, 23, 25, 27], the prevalence of AGM was 16.”
BackgroundMethodATP-sensitive K+channels in pancreatic, cardiac, and vascular smooth muscle cells
Yokoshiki, H., Sunagawa, M., Seki, T., & Sperelakis, N. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.274.1.c25 · Cited by 350 · cited 1×
“may lead to hypokalemia [31], while hypokalemia could reduce insulin secretion and lead to insulin resistance though ATP-sensitive potassium channels on the surface of islet cell [9, 32].”
BackgroundHypertension, the Potassium Ion and Impaired Carbohydrate Tolerance
Conn, J. W. (1965) · New England Journal of Medicine · doi:10.1056/nejm196511182732106 · Cited by 329 · cited 2×
“Since 1965, Conn [1] reported that insulin release curve in patients with primary aldosteronism was similar to type 2 diabetes, and also confirmed that the secondary impaired glucose tolerance might exist in such a population.”
BackgroundInsulin Sensitivity in Patients with Primary Aldosteronism: A Follow-Up Study
Catena, C., Lapenna, R., Baroselli, S., Nadalini, E., Colussi, G., Novello, M., Favret, G., Melis, A., Cavarape, A., & Sechi, L. A. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0736 · Cited by 262
The Renin Angiotensin Aldosterone System and Insulin Resistance in Humans
Underwood, P. C., & Adler, G. K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-012-0323-2 · Cited by 215 · cited 1×
“(2) Aldosterone could decreased the insulin-mediated glucose uptake by 25 % through a dose-dependent effect; addition, aldosterone can make the mitogen-activated protein kinase (MAPK) signal pathway and protein kinase B (Akt2) inactivation, which was the important part of insulin signal transduction pathway [34].”
Background
Cited by
Monticone, S., D'Ascenzo, F., Moretti, C., Williams, T. A., Veglio, F., Gaita, F., & Mulatero, P. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30319-4 · Cited by 1,072
Vaidya, A., Mulatero, P., Baudrand, R., & Adler, G. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00139 · Cited by 299
Primary aldosteronism — a multidimensional syndrome
Turcu, A. F., Yang, J., & Vaidya, A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00730-2 · Cited by 189
Primary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 150
Stanciu, S. M., Rusu, E., Miricescu, D., Radu, A. C., Axinia, B., Vrabie, A.-M., Ionescu, R. F., Jinga, M., & Sîrbu, C. A. (2023) · Metabolites · doi:10.3390/metabo13010087 · Cited by 144
Metadata
- Authors
- Chen, W., Li, F., He, C., Zhu, Y., & Tan, W.
- Affiliations
- Nanfang Hospital (CN)
- Corresponding author
- Tan, W.
- Venue
- Irish Journal of Medical Science
- Published
- 2013-08-30
- Volume
- 183
- Issue
- 2
- Pages
- 283-291
- ISSN
- 0021-1265 (ISSN-L)
- 1863-4362
- OpenAlex
- W2067816291
- Semantic Scholar
- 03541296452995dc868a60e9416ca956936ec422
- Cited by
- 53
- References
- 35
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 7 · 2018: 5 · 2017: 3 · 2016: 3 · 2015: 2
- FWCI
- 0.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Irish Journal of Medical Science (1971 -) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- primary aldosteronism, abnormal glucose metabolism, impaired fasting glucose, impaired glucose tolerance, diabetes mellitus, insulin resistance, HOMA index, insulin sensitivity, essential hypertension, prevalence
- MeSH terms
- Essential Hypertension, Blood Glucose, Fasting, Female, Glucose, Humans, Hyperaldosteronism, Hypertension, Insulin Resistance, Male, Middle Aged, Retrospective Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. https://app.cochat.ai/papers/10.1007/s11845-013-1007-x
- The paper
- Chen, W., Li, F., He, C., Zhu, Y., & Tan, W. (2014). Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis. Irish Journal of Medical Science. https://doi.org/10.1007/s11845-013-1007-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.